<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35248787</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2212-8778</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Molecular metabolism</Title><ISOAbbreviation>Mol Metab</ISOAbbreviation></Journal><ArticleTitle>Neurons undergo pathogenic metabolic reprogramming in models of familial ALS.</ArticleTitle><Pagination><StartPage>101468</StartPage><MedlinePgn>101468</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101468</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molmet.2022.101468</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2212-8778(22)00037-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Normal cellular function requires a rate of ATP production sufficient to meet demand. In most neurodegenerative diseases (including Amyotrophic Lateral Sclerosis [ALS]), mitochondrial dysfunction is postulated raising the possibility of impaired ATP production and a need for compensatory maneuvers to sustain the ATP production/demand balance. We investigated intermediary metabolism of neurons expressing familial ALS (fALS) genes and interrogated the functional consequences of glycolysis genes in fitness assays and neuronal survival.</AbstractText><AbstractText Label="METHODS">We created a pure neuronal model system for isotopologue investigations of fuel utilization. In a yeast platform we studied the functional contributions of glycolysis genes in a growth fitness assay iafter expressing of a fALS gene.</AbstractText><AbstractText Label="RESULTS">We find in our rodent models of fALS, a reduction in neuronal lactate production with maintained or enhanced activity of the neuronal citric acid cycle. This rewiring of metabolism is associated with normal ATP levels, bioenergetics, and redox status, thus supporting the notion that gross mitochondrial function is not compromised in neurons soon after expressing fALS genes. Genetic loss-of-function manipulation of individual steps in the glycolysis and the pentose phosphate pathway blunt the negative phenotypes seen in various fALS models.</AbstractText><AbstractText Label="CONCLUSIONS">We propose that neurons adjust fuel utilization in the setting of neurodegenerative disease-associated alteration in mitochondrial function in a baleful manner and targeting this process can be healthful.</AbstractText><CopyrightInformation>Published by Elsevier GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Riechers</LastName><ForeName>Sean-Patrick</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mojsilovic-Petrovic</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belton</LastName><ForeName>Tayler B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakrabarty</LastName><ForeName>Ram P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garjani</LastName><ForeName>Mehraveh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medvedeva</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalton</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Yvette C</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandel</LastName><ForeName>Navdeep S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Feinberg School of Medicine, Northwestern University, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dienel</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Arkansas for Medicine Science, United States; Department of Cell Biology and Physiology University of New Mexico, Mexico, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalb</LastName><ForeName>Robert G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, United States. Electronic address: Robert.kalb1@northwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG049665</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 NS109252</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS087077</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 CA197532</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Mol Metab</MedlineTA><NlmUniqueID>101605730</NlmUniqueID><ISSNLinking>2212-8778</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATP</Keyword><Keyword MajorTopicYN="N">G6PDH</Keyword><Keyword MajorTopicYN="N">Glycolysis</Keyword><Keyword MajorTopicYN="N">Neuron</Keyword><Keyword MajorTopicYN="N">Redox</Keyword></KeywordList><CoiStatement>Conflict of interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>6</Day><Hour>20</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35248787</ArticleId><ArticleId IdType="pmc">PMC8958550</ArticleId><ArticleId IdType="doi">10.1016/j.molmet.2022.101468</ArticleId><ArticleId IdType="pii">S2212-8778(22)00037-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Archer S.L. Mitochondrial dynamics&#x2013;mitochondrial fission and fusion in human diseases. The New England Journal of Medicine. 2013;369(23):2236&#x2013;2251. doi: 10.1056/NEJMra1215233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1215233</ArticleId><ArticleId IdType="pubmed">24304053</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787&#x2013;795. doi: 10.1038/nature05292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05292</ArticleId><ArticleId IdType="pubmed">17051205</ArticleId></ArticleIdList></Reference><Reference><Citation>Casajus Pelegay E., Puzzo F., Yilmazer A., Cagin U. Targeting mitochondrial defects to increase longevity in animal models of neurodegenerative diseases. Advances in Experimental Medicine &amp; Biology. 2019;1134(Chapter 5):89&#x2013;110. doi: 10.1007/978-3-030-12668-1_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-12668-1_5</ArticleId><ArticleId IdType="pubmed">30919333</ArticleId></ArticleIdList></Reference><Reference><Citation>Area-Gomez E., Guardia-Laguarta C., Schon E.A., Przedborski S. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas. The Journal of Clinical Investigation. 2019;129(1):34&#x2013;45. doi: 10.1172/JCI120848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI120848</ArticleId><ArticleId IdType="pmc">PMC6307938</ArticleId><ArticleId IdType="pubmed">30601141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Yan T., Perry G., Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Molecular and Cellular Neurosciences. 2019;100:103396. doi: 10.1016/j.mcn.2019.103396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.103396</ArticleId><ArticleId IdType="pmc">PMC6874890</ArticleId><ArticleId IdType="pubmed">31445085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Chen M., Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019;49:35&#x2013;45. doi: 10.1016/j.mito.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2019.07.003</ArticleId><ArticleId IdType="pubmed">31288090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaraju V., Lewis T.L., Hirabayashi Y., Bergami M., Motori E., Cartoni R., et al. Pleiotropic mitochondria: the influence of mitochondria on neuronal development and disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2019;39(42):8200&#x2013;8208. doi: 10.1523/JNEUROSCI.1157-19.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1157-19.2019</ArticleId><ArticleId IdType="pmc">PMC6794931</ArticleId><ArticleId IdType="pubmed">31619488</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan K., Anichtchik O., Luo S. Mitochondrial integrity in neurodegeneration. CNS Neuroscience and Therapeutics. 2019;25(7):825&#x2013;836. doi: 10.1111/cns.13105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13105</ArticleId><ArticleId IdType="pmc">PMC6566061</ArticleId><ArticleId IdType="pubmed">30746905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M., D'Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. The Journal of Biological Chemistry. 2002;277(33):29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Ren&#xe9; F., Gonzalez de Aguilar J.-L., Loeffler J.-P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(30):11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Sahawneh M.A., Przedborski S., Est&#xe9;vez &#xc1;.G., Manfredi G. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2012;32(1):229&#x2013;242. doi: 10.1523/JNEUROSCI.1233-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1233-11.2012</ArticleId><ArticleId IdType="pmc">PMC3566782</ArticleId><ArticleId IdType="pubmed">22219285</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung C., Higgins C.M.J., Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. Journal of Neurochemistry. 2002;83(3):535&#x2013;545. doi: 10.1046/j.1471-4159.2002.01112.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01112.x</ArticleId><ArticleId IdType="pubmed">12390515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling A.C., Schulz J.B., Brown R.H., Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. Journal of Neurochemistry. 1993;61(6):2322&#x2013;2325. doi: 10.1111/j.1471-4159.1993.tb07478.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb07478.x</ArticleId><ArticleId IdType="pubmed">8245985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G.H., Kim J.E., Rhie S.J., Yoon S. The role of oxidative stress in neurodegenerative diseases. Experimental Neurobiology. 2015;24(4):325&#x2013;340. doi: 10.5607/en.2015.24.4.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2015.24.4.325</ArticleId><ArticleId IdType="pmc">PMC4688332</ArticleId><ArticleId IdType="pubmed">26713080</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco V., Longone P., Spalloni A., Pieroni L., Urbani A. Crosstalk between oxidative stress and mitochondrial damage: focus on amyotrophic lateral sclerosis. Advances in Experimental Medicine &amp; Biology. 2019;1158:71&#x2013;82. doi: 10.1007/978-981-13-8367-0_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-8367-0_5</ArticleId><ArticleId IdType="pubmed">31452136</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirie E., Oh C.-K., Zhang X., Han X., Cieplak P., Scott H.R., et al. S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in&#xa0;vivo models of ALS/FTD. Proceedings of the National Academy of Sciences of the United States of America. 2021;118(11) doi: 10.1073/pnas.2021368118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2021368118</ArticleId><ArticleId IdType="pmc">PMC7980404</ArticleId><ArticleId IdType="pubmed">33692125</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neuroscience Letters. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques E.P., Wyse A.T.S. Creatine as a neuroprotector: an actor that can play many parts. Neurotoxicity Research. 2019;36(2):411&#x2013;423. doi: 10.1007/s12640-019-00053-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-019-00053-7</ArticleId><ArticleId IdType="pubmed">31069754</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., De Bock K., Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathologica. 2018;135(4):489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nature Cell Biology. 2011;13(9):1016&#x2013;1023. doi: 10.1038/ncb2329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2329</ArticleId><ArticleId IdType="pmc">PMC3249400</ArticleId><ArticleId IdType="pubmed">21892142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology. 2012;13(4):251&#x2013;262. doi: 10.1038/nrm3311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3311</ArticleId><ArticleId IdType="pmc">PMC5726489</ArticleId><ArticleId IdType="pubmed">22436748</ArticleId></ArticleIdList></Reference><Reference><Citation>Dienel G.A. Brain glucose metabolism: integration of energetics with function. Physiological Reviews. 2019;99(1):949&#x2013;1045. doi: 10.1152/physrev.00062.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00062.2017</ArticleId><ArticleId IdType="pubmed">30565508</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Herman P., Rothman D.L., Agarwal D., Hyder F. Evaluating the gray and white matter energy budgets of human brain function. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2018;38(8):1339&#x2013;1353. doi: 10.1177/0271678X17708691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X17708691</ArticleId><ArticleId IdType="pmc">PMC6092772</ArticleId><ArticleId IdType="pubmed">28589753</ArticleId></ArticleIdList></Reference><Reference><Citation>Licznerski P., Park H.-A., Rolyan H., Chen R., Mnatsakanyan N., Miranda P., et al. ATP synthase c-subunit leak causes aberrant cellular metabolism in fragile X syndrome. Cell. 2020;182(5):1170&#x2013;1179. doi: 10.1016/j.cell.2020.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.008</ArticleId><ArticleId IdType="pmc">PMC7484101</ArticleId><ArticleId IdType="pubmed">32795412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaraju V., Calloway N., Ryan T.A. Activity-driven local ATP synthesis is required for synaptic function. Cell. 2014;156(4):825&#x2013;835. doi: 10.1016/j.cell.2013.12.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.12.042</ArticleId><ArticleId IdType="pmc">PMC3955179</ArticleId><ArticleId IdType="pubmed">24529383</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann K., Deny S., Ganguli S., Clandinin T.R. Coupling of activity, metabolism and behaviour across the Drosophila brain. Nature. 2021;593(7858):244&#x2013;248. doi: 10.1038/s41586-021-03497-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03497-0</ArticleId><ArticleId IdType="pubmed">33911283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C.N., Klein-Fl&#xfc;gge M.C., Howarth C., Attwell D. Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2012;32(26):8940&#x2013;8951. doi: 10.1523/JNEUROSCI.0026-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0026-12.2012</ArticleId><ArticleId IdType="pmc">PMC3390246</ArticleId><ArticleId IdType="pubmed">22745494</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBerardinis R.J., Chandel N.S. Fundamentals of cancer metabolism. Science Advances. 2016;2(5) doi: 10.1126/sciadv.1600200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1600200</ArticleId><ArticleId IdType="pmc">PMC4928883</ArticleId><ArticleId IdType="pubmed">27386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood T. Physiological functions of the pentose phosphate pathway. Cell Biochemistry and Function. 1986;4(4):241&#x2013;247. doi: 10.1002/cbf.290040403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.290040403</ArticleId><ArticleId IdType="pubmed">3539386</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanton R.C. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life. 2012;64(5):362&#x2013;369. doi: 10.1002/iub.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1017</ArticleId><ArticleId IdType="pmc">PMC3325335</ArticleId><ArticleId IdType="pubmed">22431005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kletzien R.F., Harris P.K., Foellmi L.A. Glucose-6-phosphate dehydrogenase: a &#x201c;housekeeping&#x201d; enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. Federation of American Societies for Experimental Biology Journal: Official Publication of the Federation of American Societies for Experimental Biology. 1994;8(2):174&#x2013;181. doi: 10.1096/fasebj.8.2.8119488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.8.2.8119488</ArticleId><ArticleId IdType="pubmed">8119488</ArticleId></ArticleIdList></Reference><Reference><Citation>Denzel M.S., Storm N.J., Gutschmidt A., Baddi R., Hinze Y., Jarosch E., et al. Hexosamine pathway metabolites enhance protein quality control and prolong life. Cell. 2014;156(6):1167&#x2013;1178. doi: 10.1016/j.cell.2014.01.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.01.061</ArticleId><ArticleId IdType="pubmed">24630720</ArticleId></ArticleIdList></Reference><Reference><Citation>Slawson C., Hart G.W. O-GlcNAc signalling: implications for cancer cell biology. Nature Reviews Cancer. 2011;11(9):678&#x2013;684. doi: 10.1038/nrc3114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3114</ArticleId><ArticleId IdType="pmc">PMC3291174</ArticleId><ArticleId IdType="pubmed">21850036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.V., Deng Y., Gao N., Pedrozo Z., Li D.L., Morales C.R., et al. Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway. Cell. 2014;156(6):1179&#x2013;1192. doi: 10.1016/j.cell.2014.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.01.014</ArticleId><ArticleId IdType="pmc">PMC3959665</ArticleId><ArticleId IdType="pubmed">24630721</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Yin N., Peng M., Stamatiades E.G., Shyu A., Li P., et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science (New York, N.Y.) 2021;371(6527):405&#x2013;410. doi: 10.1126/science.abb2683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2683</ArticleId><ArticleId IdType="pmc">PMC8380312</ArticleId><ArticleId IdType="pubmed">33479154</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojsilovic-Petrovic J., Jeong G.-B., Crocker A., Arneja A., David S., Russell D.S., et al. Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2006;26(36):9250&#x2013;9263. doi: 10.1523/JNEUROSCI.1856-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1856-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674510</ArticleId><ArticleId IdType="pubmed">16957081</ArticleId></ArticleIdList></Reference><Reference><Citation>Waagepetersen H.S., Sonnewald U., Larsson O.M., Schousboe A. Compartmentation of TCA cycle metabolism in cultured neocortical neurons revealed by 13C MR spectroscopy. Neurochemistry International. 2000;36(4&#x2013;5):349&#x2013;358. doi: 10.1016/s0197-0186(99)00143-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-0186(99)00143-6</ArticleId><ArticleId IdType="pubmed">10733002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnewald U., Hertz L., Schousboe A. Mitochondrial heterogeneity in the brain at the cellular level. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 1998;18(3):231&#x2013;237. doi: 10.1097/00004647-199803000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004647-199803000-00001</ArticleId><ArticleId IdType="pubmed">9498839</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67(4):575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43(1):19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J., et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nature Medicine. 2016;22(8):869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.C., Walsh J.M., Dennis S.C., Clark J.B. Synaptic and non-synaptic mitochondria from rat brain: isolation and characterization. Journal of Neurochemistry. 1977;28(3):625&#x2013;631. doi: 10.1111/j.1471-4159.1977.tb10434.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1977.tb10434.x</ArticleId><ArticleId IdType="pubmed">16086</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong S.F., Lai J.C., Lim L., Clark J.B. The activities of some energy-metabolising enzymes in nonsynaptic (free) and synaptic mitochondria derived from selected brain regions. Journal of Neurochemistry. 1984;42(5):1306&#x2013;1312. doi: 10.1111/j.1471-4159.1984.tb02788.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1984.tb02788.x</ArticleId><ArticleId IdType="pubmed">6707635</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola M., Higgins M.J., Figley M.D., Barmada S.J., Scarborough E.A., Diaz Z., et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nature Genetics. 2012;44(12):1302&#x2013;1309. doi: 10.1038/ng.2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2434</ArticleId><ArticleId IdType="pmc">PMC3510335</ArticleId><ArticleId IdType="pubmed">23104007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim M.A., Selak M.A., Xiang Z., Krainc D., Neve R.L., Kraemer B.C., et al. Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2012;32(3):1123&#x2013;1141. doi: 10.1523/JNEUROSCI.6554-10.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6554-10.2012</ArticleId><ArticleId IdType="pmc">PMC3742882</ArticleId><ArticleId IdType="pubmed">22262909</ArticleId></ArticleIdList></Reference><Reference><Citation>Periz G., Lu J., Zhang T., Kankel M.W., Jablonski A.M., Kalb R., et al. Regulation of protein quality control by UBE4B and LSD1 through p53-mediated transcription. PLoS Biology. 2015;13(4) doi: 10.1371/journal.pbio.1002114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002114</ArticleId><ArticleId IdType="pmc">PMC4383508</ArticleId><ArticleId IdType="pubmed">25837623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai J., Zhang L., Mojsilovic-Petrovic J., Jian X., Thomas J., Homma K., et al. Inhibition of cytohesins protects against genetic models of motor neuron disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2015;35(24):9088&#x2013;9105. doi: 10.1523/JNEUROSCI.5032-13.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5032-13.2015</ArticleId><ArticleId IdType="pmc">PMC4469736</ArticleId><ArticleId IdType="pubmed">26085633</ArticleId></ArticleIdList></Reference><Reference><Citation>Jablonski A.M., Lamitina T., Liachko N.F., Sabatella M., Lu J., Zhang L., et al. Loss of RAD-23 protects against models of motor neuron disease by enhancing mutant protein clearance. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2015;35(42):14286&#x2013;14306. doi: 10.1523/JNEUROSCI.0642-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0642-15.2015</ArticleId><ArticleId IdType="pmc">PMC4683688</ArticleId><ArticleId IdType="pubmed">26490867</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojsilovic-Petrovic J., Nedelsky N., Boccitto M., Mano I., Georgiades S.N., Zhou W., et al. FOXO3a is broadly neuroprotective in&#xa0;vitro and in&#xa0;vivo against insults implicated in motor neuron diseases. Journal of Neuroscience. 2009;29(25):8236&#x2013;8247. doi: 10.1523/JNEUROSCI.1805-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1805-09.2009</ArticleId><ArticleId IdType="pmc">PMC2748231</ArticleId><ArticleId IdType="pubmed">19553463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in&#xa0;vitro and in&#xa0;vivo neuronal death. Neuron. 2014;84(6):1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.-L., DeJesus-Hernandez M., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77(4):639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gr&#xf6;nke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science (New York, N.Y.) 2014;345(6201):1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Lan M., Mojsilovic-Petrovic J., Choi W.H., Safren N., Barmada S., et al. The proline/arginine dipeptide from hexanucleotide repeat ExpandedC9ORF72Inhibits the proteasome. eNeuro. 2017;4(1) doi: 10.1523/ENEURO.0249-16.2017. ENEURO.0249&#x2013;16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0249-16.2017</ArticleId><ArticleId IdType="pmc">PMC5282547</ArticleId><ArticleId IdType="pubmed">28197542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghergurovich J.M., Garc&#xed;a-Ca&#xf1;averas J.C., Wang J., Schmidt E., Zhang Z., TeSlaa T., et al. A&#xa0;small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. Nature Chemical Biology. 2020;16(7):731&#x2013;739. doi: 10.1038/s41589-020-0533-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-020-0533-x</ArticleId><ArticleId IdType="pmc">PMC7311271</ArticleId><ArticleId IdType="pubmed">32393898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton K.A., Cudkowicz M.E., Brown M.V., Alexander D., Caffrey R., Wulff J.E., et al. Biochemical alterations associated with ALS. Null. 2012;13(1):110&#x2013;118. doi: 10.3109/17482968.2011.619197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.619197</ArticleId><ArticleId IdType="pubmed">22117131</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T., Jiao Y., Ferrando L.M., Yablonska S., Li F., Horoszko E.C., et al. Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated. Scientific Reports. 2021;11(1) doi: 10.1038/s41598-021-97928-7. 18916&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-97928-7</ArticleId><ArticleId IdType="pmc">PMC8460779</ArticleId><ArticleId IdType="pubmed">34556702</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Liu H., Itoh K., Oh S., Zhao L., Murata D., et al. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metabolism. 2021;33(3):531&#x2013;539. doi: 10.1016/j.cmet.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC8579819</ArticleId><ArticleId IdType="pubmed">33545050</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves C.J., Dariolli R., Jorge F.M., Monteiro M.R., Maximino J.R., Martins R.S., et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Frontiers in Cellular Neuroscience. 2015;9:289. doi: 10.3389/fncel.2015.00289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00289</ArticleId><ArticleId IdType="pmc">PMC4523944</ArticleId><ArticleId IdType="pubmed">26300727</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin E.C., Madji Hounoum B., Bannwarth S., Fragaki K., Lacas-Gervais S., Mauri-Crouzet A., et al. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ mouse. Acta Neuropathologica. 2019;138(1):123&#x2013;145. doi: 10.1007/s00401-019-01988-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01988-z</ArticleId><ArticleId IdType="pubmed">30874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., Wainger B.J., et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14(6):781&#x2013;795. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Lee J.J., Park N.Y., Dubey S.K., Kim T., Ruan K., et al. Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nature Neuroscience. 2021;24(12):1673&#x2013;1685. doi: 10.1038/s41593-021-00944-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00944-z</ArticleId><ArticleId IdType="pmc">PMC8639773</ArticleId><ArticleId IdType="pubmed">34782793</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson C.J., Bredvik K., Burstein S.R., Davis C., Meadows S.M., Dash J., et al. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathologica. 2019;138(1):103&#x2013;121. doi: 10.1007/s00401-019-01989-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01989-y</ArticleId><ArticleId IdType="pmc">PMC6571048</ArticleId><ArticleId IdType="pubmed">30877432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Deng J., Dong J., Liu J., Bigio E.H., Mesulam M., et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genetics. 2019;15(5) doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub I.R., Janer A., Weraarpachai W., Zinman L., Robertson J., Rogaeva E., et al. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Human Molecular Genetics. 2018;27(1):178&#x2013;189. doi: 10.1093/hmg/ddx393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx393</ArticleId><ArticleId IdType="pmc">PMC5886208</ArticleId><ArticleId IdType="pubmed">29121267</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek M., Choe Y.-J., Bannwarth S., Kim J., Maitra S., Dorn G.W., et al. TDP-43 and PINK1 mediate CHCHD10S59L mutation-induced defects in Drosophila and in&#xa0;vitro. Nature Communications. 2021;12(1):1924&#x2013;2020. doi: 10.1038/s41467-021-22145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22145-9</ArticleId><ArticleId IdType="pmc">PMC7997989</ArticleId><ArticleId IdType="pubmed">33772006</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.-H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell. 2020;183(3):636&#x2013;649.e18. doi: 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Parone P.A., Da Cruz S., Han J.S., McAlonis-Downes M., Vetto A.P., Lee S.K., et al. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2013;33(11):4657&#x2013;4671. doi: 10.1523/JNEUROSCI.1119-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1119-12.2013</ArticleId><ArticleId IdType="pmc">PMC3711648</ArticleId><ArticleId IdType="pubmed">23486940</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W., Naniche N., Bogush A., Pedrini S., Trotti D., Pasinelli P. Small peptides against the mutant SOD1/Bcl-2 toxic mitochondrial complex restore mitochondrial function and cell viability in mutant SOD1-mediated ALS. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2013;33(28):11588&#x2013;11598. doi: 10.1523/JNEUROSCI.5385-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5385-12.2013</ArticleId><ArticleId IdType="pmc">PMC3724557</ArticleId><ArticleId IdType="pubmed">23843527</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.Y., Lopez-Gonzalez R., Krishnan G., Phillips H.L., Li A.N., Seeley W.W., et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in&#xa0;vivo. Nature Neuroscience. 2019;22(6):851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.-C., Hung W.-T., Chang Y.-C., Chang H.C., Wu C.-L., Chiang A.-S., et al. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model. PLoS Genetics. 2011;7(2) doi: 10.1371/journal.pgen.1001288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1001288</ArticleId><ArticleId IdType="pmc">PMC3033380</ArticleId><ArticleId IdType="pubmed">21304887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N.C., Tresse E., Kolaitis R.-M., Molliex A., Thomas R.E., Alami N.H., et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013;78(1):65&#x2013;80. doi: 10.1016/j.neuron.2013.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.029</ArticleId><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolome F., Wu H.-C., Burchell V.S., Preza E., Wray S., Mahoney C.J., et al. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron. 2013;78(1):57&#x2013;64. doi: 10.1016/j.neuron.2013.02.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.028</ArticleId><ArticleId IdType="pmc">PMC3843114</ArticleId><ArticleId IdType="pubmed">23498975</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Wu Z., Li Y., Tantray I., De Stefani D., Mattarei A., et al. Altered MICOS morphology and mitochondrial ion homeostasis contribute to poly(GR) toxicity associated with C9-ALS/FTD. Cell Reports. 2020;32(5):107989. doi: 10.1016/j.celrep.2020.107989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107989</ArticleId><ArticleId IdType="pmc">PMC7433775</ArticleId><ArticleId IdType="pubmed">32755582</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena G.N., Rizzardini M., Cimini S., Siskos A.P., Bendotti C., Cantoni L., et al. Metabolomic analysis reveals increased aerobic glycolysis and amino acid deficit in a cellular model of amyotrophic lateral sclerosis. Molecular Neurobiology. 2016;53(4):2222&#x2013;2240. doi: 10.1007/s12035-015-9165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9165-7</ArticleId><ArticleId IdType="pmc">PMC4823370</ArticleId><ArticleId IdType="pubmed">25963727</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Rajan S., Duffy L., Mortiboys H., Higginbottom A., Grierson A.J., et al. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiology of Aging. 2014;35(6):1499&#x2013;1509. doi: 10.1016/j.neurobiolaging.2013.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.025</ArticleId><ArticleId IdType="pubmed">24439480</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E., Lorenzini I., Barrameda D., O'Conner A.G., Barrows J.M., Starr A., et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife. 2019;8:606. doi: 10.7554/eLife.45114.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Bartlett K., Tran S.S., Hodson M.P., Borges K. Impaired pentose phosphate pathway in the spinal cord of the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Molecular Neurobiology. 2019;56(8):5844&#x2013;5855. doi: 10.1007/s12035-019-1485-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1485-6</ArticleId><ArticleId IdType="pubmed">30685842</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Borges K. Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2019;39(9):1710&#x2013;1724. doi: 10.1177/0271678X18764775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X18764775</ArticleId><ArticleId IdType="pmc">PMC6727138</ArticleId><ArticleId IdType="pubmed">29553298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziller M.J., Ortega J.A., Quinlan K.A., Santos D.P., Gu H., Martin E.J., et al. Dissecting the functional consequences of De Novo DNA methylation dynamics in human motor neuron differentiation and physiology. Cell Stem Cell. 2018 doi: 10.1016/j.stem.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2018.02.012</ArticleId><ArticleId IdType="pmc">PMC6535433</ArticleId><ArticleId IdType="pubmed">29551301</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega J.A., Daley E.L., Kour S., Samani M., Tellez L., Smith H.S., et al. Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron. 2020;106(1):90&#x2013;107.e13. doi: 10.1016/j.neuron.2020.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.01.020</ArticleId><ArticleId IdType="pmc">PMC7272217</ArticleId><ArticleId IdType="pubmed">32059759</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(22):10625&#x2013;10629. doi: 10.1073/pnas.91.22.10625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.22.10625</ArticleId><ArticleId IdType="pmc">PMC45074</ArticleId><ArticleId IdType="pubmed">7938003</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolivet R., Allaman I., Pellerin L., Magistretti P.J., Weber B. Comment on recent modeling studies of astrocyte-neuron metabolic interactions. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2010;30(12):1982&#x2013;1986. doi: 10.1038/jcbfm.2010.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2010.132</ArticleId><ArticleId IdType="pmc">PMC3002878</ArticleId><ArticleId IdType="pubmed">20700131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangia S., DiNuzzo M., Giove F., Carruthers A., Simpson I.A., Vannucci S.J. Response to &#x201c;comment on recent modeling studies of astrocyte-neuron metabolic interactions&#x201d;: much ado about nothing. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2011;31(6):1346&#x2013;1353. doi: 10.1038/jcbfm.2011.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.29</ArticleId><ArticleId IdType="pmc">PMC3130323</ArticleId><ArticleId IdType="pubmed">21427731</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.S., Burckhardt C.J., Lazcano R., Solis L.M., Isogai T., Li L., et al. Mechanical regulation of glycolysis via cytoskeleton architecture. Nature. 2020;578(7796):621&#x2013;626. doi: 10.1038/s41586-020-1998-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1998-1</ArticleId><ArticleId IdType="pmc">PMC7210009</ArticleId><ArticleId IdType="pubmed">32051585</ArticleId></ArticleIdList></Reference><Reference><Citation>Zala D., Hinckelmann M.-V., Yu H., Lyra da Cunha M.M., Liot G., Cordeli&#xe8;res F.P., et al. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell. 2013;152(3):479&#x2013;491. doi: 10.1016/j.cell.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.12.029</ArticleId><ArticleId IdType="pubmed">23374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., Fuller G.G., Han T., Yao Y., Alessi A.F., Freeberg M.A., et al. Glycolytic enzymes coalesce in G bodies under hypoxic stress. Cell Reports. 2017;20(4):895&#x2013;908. doi: 10.1016/j.celrep.2017.06.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.06.082</ArticleId><ArticleId IdType="pmc">PMC5586494</ArticleId><ArticleId IdType="pubmed">28746874</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.-S., Hsu J.-W., Park S.-Y., Li J., Oldham W.M., Beznoussenko G.V., et al. GAPDH inhibits intracellular pathways during starvation for cellular energy homeostasis. Nature. 2018;561(7722):263&#x2013;267. doi: 10.1038/s41586-018-0475-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0475-6</ArticleId><ArticleId IdType="pmc">PMC6152935</ArticleId><ArticleId IdType="pubmed">30209366</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.-S., Hsu J.-W., Park S.-Y., Lee S.Y., Li J., Bai M., et al. ALDH7A1 inhibits the intracellular transport pathways during hypoxia and starvation to promote cellular energy homeostasis. Nature Communications. 2019;10(1):1&#x2013;15. doi: 10.1038/s41467-019-11932-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11932-0</ArticleId><ArticleId IdType="pmc">PMC6731274</ArticleId><ArticleId IdType="pubmed">31492851</ArticleId></ArticleIdList></Reference><Reference><Citation>Tristan C., Shahani N., Sedlak T.W., Sawa A. The diverse functions of GAPDH: views from different subcellular compartments. Cellular Signalling. 2011;23(2):317&#x2013;323. doi: 10.1016/j.cellsig.2010.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2010.08.003</ArticleId><ArticleId IdType="pmc">PMC3084531</ArticleId><ArticleId IdType="pubmed">20727968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.H., Cha M., Lee B.H. Neuroprotective effect of antioxidants in the brain. International Journal of Molecular Sciences. 2020;21(19):7152. doi: 10.3390/ijms21197152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197152</ArticleId><ArticleId IdType="pmc">PMC7582347</ArticleId><ArticleId IdType="pubmed">32998277</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransen M., Revenco I., Li H., Costa C.F., Lismont C., Van Veldhoven P.P. Peroxisomal dysfunction and oxidative stress in neurodegenerative disease: a bidirectional crosstalk. Advances in Experimental Medicine &amp; Biology. 2020;1299:19&#x2013;30. doi: 10.1007/978-3-030-60204-8_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-60204-8_2</ArticleId><ArticleId IdType="pubmed">33417204</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Mead R.J., Shaw P.J. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochimica Et Biophysica Acta. 2006;1762(11&#x2013;12):1051&#x2013;1067. doi: 10.1016/j.bbadis.2006.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.008</ArticleId><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorce S., Stocker R., Seredenina T., Holmdahl R., Aguzzi A., Chi&#xf2; A., et al. NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: what is the evidence? Free Radical Biology &amp; Medicine. 2017;112:387&#x2013;396. doi: 10.1016/j.freeradbiomed.2017.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.08.006</ArticleId><ArticleId IdType="pubmed">28811143</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Itoyama Y., Sobue G., Tsuji S., Aoki M., Doyu M., et al. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration. 2014;15(7&#x2013;8):610&#x2013;617. doi: 10.3109/21678421.2014.959024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959024</ArticleId><ArticleId IdType="pmc">PMC4266079</ArticleId><ArticleId IdType="pubmed">25286015</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan A.M., Suh S.W., Won S.J., Narasimhan P., Kauppinen T.M., Lee H., et al. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nature Neuroscience. 2009;12(7):857&#x2013;863. doi: 10.1038/nn.2334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2334</ArticleId><ArticleId IdType="pmc">PMC2746760</ArticleId><ArticleId IdType="pubmed">19503084</ArticleId></ArticleIdList></Reference><Reference><Citation>Leopold J.A., Walker J., Scribner A.W., Voetsch B., Zhang Y.-Y., Loscalzo A.J., et al. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. The Journal of Biological Chemistry. 2003;278(34):32100&#x2013;32106. doi: 10.1074/jbc.M301293200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301293200</ArticleId><ArticleId IdType="pubmed">12777375</ArticleId></ArticleIdList></Reference><Reference><Citation>Leopold J.A., Zhang Y.-Y., Scribner A.W., Stanton R.C., Loscalzo J. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23(3):411&#x2013;417. doi: 10.1161/01.ATV.0000056744.26901.BA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000056744.26901.BA</ArticleId><ArticleId IdType="pubmed">12615686</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrali G., Casale F., Salamone P., Fuda G., Caorsi C., Amoroso A., et al. NADPH oxidase (NOX2) activity is a modifier of survival in ALS. Journal of Neurology. 2014;261(11):2178&#x2013;2183. doi: 10.1007/s00415-014-7470-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7470-0</ArticleId><ArticleId IdType="pubmed">25178511</ArticleId></ArticleIdList></Reference><Reference><Citation>Seredenina T., Nayernia Z., Sorce S., Maghzal G.J., Filippova A., Ling S.-C., et al. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis. Free Radical Biology &amp; Medicine. 2016;97:95&#x2013;108. doi: 10.1016/j.freeradbiomed.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.05.016</ArticleId><ArticleId IdType="pubmed">27212019</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A., Za&#xef;di S., Iltis C., Ribon M., Berriat F., Schiaffino L., et al. Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nature Neuroscience. 2020;23(11):1339&#x2013;1351. doi: 10.1038/s41593-020-00718-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00718-z</ArticleId><ArticleId IdType="pubmed">33077946</ArticleId></ArticleIdList></Reference><Reference><Citation>Drechsel D.A., Est&#xe9;vez &#xc1;.G., Barbeito L., Beckman J.S. Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotoxicity Research. 2012;22(4):251&#x2013;264. doi: 10.1007/s12640-012-9322-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-012-9322-y</ArticleId><ArticleId IdType="pmc">PMC4145402</ArticleId><ArticleId IdType="pubmed">22488161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhang X., Li C., Guan T., Shang H., Cui L., et al. S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis. Journal of Neurochemistry. 2013;124(1):45&#x2013;58. doi: 10.1111/jnc.12046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12046</ArticleId><ArticleId IdType="pubmed">23043510</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajasekaran N.S., Connell P., Christians E.S., Yan L.-J., Taylor R.P., Orosz A., et al. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell. 2007;130(3):427&#x2013;439. doi: 10.1016/j.cell.2007.06.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.06.044</ArticleId><ArticleId IdType="pmc">PMC2962423</ArticleId><ArticleId IdType="pubmed">17693254</ArticleId></ArticleIdList></Reference><Reference><Citation>Luzzatto L., Nannelli C., Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematology/Oncology Clinics of North America. 2016;30(2):373&#x2013;393. doi: 10.1016/j.hoc.2015.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hoc.2015.11.006</ArticleId><ArticleId IdType="pubmed">27040960</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia A.A., Koperniku A., Ferreira J.C.B., Mochly-Rosen D. Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives. Trends in Pharmacological Sciences. 2021;42(10):829&#x2013;844. doi: 10.1016/j.tips.2021.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2021.07.002</ArticleId><ArticleId IdType="pmc">PMC8448981</ArticleId><ArticleId IdType="pubmed">34389161</ArticleId></ArticleIdList></Reference><Reference><Citation>Savaki H.E., Davidsen L., Smith C., Sokoloff L. Measurement of free glucose turnover in brain. Journal of Neurochemistry. 1980;35(2):495&#x2013;502. doi: 10.1111/j.1471-4159.1980.tb06293.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1980.tb06293.x</ArticleId><ArticleId IdType="pubmed">7452269</ArticleId></ArticleIdList></Reference><Reference><Citation>Veech R.L., Harris R.L., Veloso D., Veech E.H. Freeze-blowing: a new technique for the study of brain in&#xa0;vivo. Journal of Neurochemistry. 1973;20(1):183&#x2013;188. doi: 10.1111/j.1471-4159.1973.tb12115.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1973.tb12115.x</ArticleId><ArticleId IdType="pubmed">4405707</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissim I., Horyn O., Nissim I., Daikhin Y., Wehrli S.L., Yudkoff M., et al. Effects of a glucokinase activator on hepatic intermediary metabolism: study with 13C-isotopomer-based metabolomics. The Biochemical Journal. 2012;444(3):537&#x2013;551. doi: 10.1042/BJ20120163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20120163</ArticleId><ArticleId IdType="pmc">PMC3679927</ArticleId><ArticleId IdType="pubmed">22448977</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Qiu B., Lee D.S.M., Walton Z.E., Ochocki J.D., Mathew L.K., et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature. 2014;513(7517):251&#x2013;255. doi: 10.1038/nature13557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13557</ArticleId><ArticleId IdType="pmc">PMC4162811</ArticleId><ArticleId IdType="pubmed">25043030</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Nissim I., Chen P., Buettger C., Najafi H., Daikhin Y., et al. Elimination of KATP channels in mouse islets results in elevated [U-13C]glucose metabolism, glutaminolysis, and pyruvate cycling but a decreased gamma-aminobutyric acid shunt. The Journal of Biological Chemistry. 2008;283(25):17238&#x2013;17249. doi: 10.1074/jbc.M709235200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M709235200</ArticleId><ArticleId IdType="pmc">PMC2427330</ArticleId><ArticleId IdType="pubmed">18445600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissim I., Horyn O., Daikhin Y., Chen P., Li C., Wehrli S.L., et al. The molecular and metabolic influence of long term agmatine consumption. The Journal of Biological Chemistry. 2014;289(14):9710&#x2013;9729. doi: 10.1074/jbc.M113.544726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.544726</ArticleId><ArticleId IdType="pmc">PMC3975019</ArticleId><ArticleId IdType="pubmed">24523404</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg J.M., Venkatachalam M.A., Roeser N.F., Nissim I. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(6):2826&#x2013;2831. doi: 10.1073/pnas.97.6.2826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.6.2826</ArticleId><ArticleId IdType="pmc">PMC16014</ArticleId><ArticleId IdType="pubmed">10717001</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore T., Le A., Niemi A.-K., Kwan T., Cusmano-Ozog K., Enns G.M., et al. A&#xa0;new LC-MS/MS method for the clinical determination of reduced and oxidized glutathione from whole blood. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2013;929:51&#x2013;55. doi: 10.1016/j.jchromb.2013.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2013.04.004</ArticleId><ArticleId IdType="pubmed">23660247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.N., Boros L.G., Puigjaner J., Bassilian S., Lim S., Cascante M. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. The American Journal of Physiology. 1998;274(5):E843&#x2013;E851. doi: 10.1152/ajpendo.1998.274.5.E843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.1998.274.5.E843</ArticleId><ArticleId IdType="pubmed">9612242</ArticleId></ArticleIdList></Reference><Reference><Citation>van Geersdaele L.K., Stead M.A., Harrison C.M., Carr S.B., Close H.J., Rosbrook G.O., et al. Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP. Acta Crystallographica. Section D, Biological Crystallography. 2013;69(Pt 9):1677&#x2013;1684. doi: 10.1107/S0907444913012687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444913012687</ArticleId><ArticleId IdType="pubmed">23999291</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S., Nelson J.C., Bend E.G., Rodr&#xed;guez-Laureano L., Tueros F.G., Cartagenova L., et al. Glycolytic enzymes localize to synapses under energy stress to support synaptic function. Neuron. 2016;90(2):278&#x2013;291. doi: 10.1016/j.neuron.2016.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.03.011</ArticleId><ArticleId IdType="pmc">PMC4840048</ArticleId><ArticleId IdType="pubmed">27068791</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Xiong G.-J., Huang N., Sheng Z.-H. The cross-talk of energy sensing and mitochondrial anchoring sustains synaptic efficacy by maintaining presynaptic metabolism. Nature Metabolism. 2020;2(10):1077&#x2013;1095. doi: 10.1038/s42255-020-00289-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00289-0</ArticleId><ArticleId IdType="pmc">PMC7572785</ArticleId><ArticleId IdType="pubmed">33020662</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen K., Sloan S.A., Bennett M.L., Scholze A.R., O'Keeffe S., et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2014;34(36):11929&#x2013;11947. doi: 10.1523/JNEUROSCI.1860-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1860-14.2014</ArticleId><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Johmura Y., Yamanaka T., Omori S., Wang T.-W., Sugiura Y., Matsumoto M., et al. Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science (New York, N.Y.) 2021;371(6526):265&#x2013;270. doi: 10.1126/science.abb5916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb5916</ArticleId><ArticleId IdType="pubmed">33446552</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin R.M., Fu X., Pai M.Y., Vergnes L., Hwang H., Deng G., et al. The metabolite &#x3b1;-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature. 2014;510(7505):397&#x2013;401. doi: 10.1038/nature13264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13264</ArticleId><ArticleId IdType="pmc">PMC4263271</ArticleId><ArticleId IdType="pubmed">24828042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut P., Verdin E. The nexus of chromatin regulation and intermediary metabolism. Nature. 2013;502(7472):489&#x2013;498. doi: 10.1038/nature12752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12752</ArticleId><ArticleId IdType="pubmed">24153302</ArticleId></ArticleIdList></Reference><Reference><Citation>Brachmann C.B., Davies A., Cost G.J., Caputo E., Li J., Hieter P., et al. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast (Chichester, England) 1998;14(2):115&#x2013;132. doi: 10.1002/(SICI)1097-0061(19980130)14:2&lt;115::AID-YEA204&gt;3.0.CO;2-132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0061(19980130)14:2&lt;115::AID-YEA204&gt;3.0.CO;2-132</ArticleId><ArticleId IdType="pubmed">9483801</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee M.K., Haase S.B. New and redesigned pRS plasmid shuttle vectors for genetic manipulation of Saccharomycescerevisiae. G3: Genes &#x2013; Genomes &#x2013; Genetics. 2012;2(5):515&#x2013;526. doi: 10.1534/g3.111.001917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.111.001917</ArticleId><ArticleId IdType="pmc">PMC3362935</ArticleId><ArticleId IdType="pubmed">22670222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito H., Fukuda Y., Murata K., Kimura A. Transformation of intact yeast cells treated with alkali cations. Journal of Bacteriology. 1983;153(1):163&#x2013;168. doi: 10.1128/JB.153.1.163-168.1983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.153.1.163-168.1983</ArticleId><ArticleId IdType="pmc">PMC217353</ArticleId><ArticleId IdType="pubmed">6336730</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., Shorter J., DeJesus-Hernandez M., Erion R., Oristano R., et al. A&#xa0;yeast functional screen predicts new candidate ALS disease genes. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(52):20881&#x2013;20890. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1213120</ArticleId><ArticleId IdType="pubmed">4366476</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbaum-Krammer C.I., Neto M.F., Brielmann R.M., Pedersen J.S., Morimoto R.I. Investigating the spreading and toxicity of prion-like proteins using the metazoan model organism C.&#xa0;elegans. Journal of Visualized Experiments: Journal of Visualized Experiments. 2015;(95):52321. doi: 10.3791/52321.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52321</ArticleId><ArticleId IdType="pmc">PMC4354510</ArticleId><ArticleId IdType="pubmed">25591151</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>